2nd Apr 2012 14:31
GW Pharmaceuticals PLC
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 2 April 2012: GW Pharmaceuticals (AIM: GWP) hereby provides notification that the Company was notified on 31 March 2012 of the following share transactions entered into by Dr Stephen Wright, a Director of the Company.
On 31 March 2012, Dr Wright exercised share options over 140,000 new GW Pharmaceuticals plc ordinary shares of 0.1 pence each with an exercise price of 0.1 pence per share. The resulting new ordinary shares, representing 0.11% of the Company's issued share capital, were immediately sold at the market price of 87.0 pence per share.
Following these transactions, Stephen Wright continues to hold a beneficial interest in 5,000 GW Pharmaceuticals plc 0.1 pence ordinary shares, representing 0.004% of the Company's issued share capital.
The total number of shares outstanding in the Company is 133,287,354 ordinary shares of 0.1 pence each.
- Ends -
Enquiries:
GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900
James Steel/Vijay Barathan
Related Shares:
GWP.L